Androgens, which play a crucial role in prostate carcinogenesis, have been shown to increase LC3-II levels and GFP-LC3 puncta, as well as mCherry-GFP-LC3 flux in LNCaP and VCaP cells (Shi et al., 2013). This evidence concerns the gene MAP1LC3A and medical procedure.